ISRAEL’S MEDICAL ACHIEVEMENTS
US approves two Teva asthma treatments. The US FDA has approved two treatments developed by Israel’s Teva, for adolescents and adults with asthma. They are AirDuo RespiClick (fluticasone propionate and salmeterol inhalation powder) and ArmonAir RespiClick (fluticasone propionate inhalation powder).
http://www.globes.co.il/en/article-fda-approves-two-teva-asthma-treatments-1001174386
Combatting fatty liver disease. (TY Atid-EDI) In advance of Phase 2 trials, preclinical data showed the potential efficacy of Namodenoson (CF102) from Israel’s Can-Fite (see Jan 2012). It inhibited the growth and proliferation of liver fibrosis cells, supporting its potential ability to combat non-alcoholic fatty liver disease.
http://ir.canfite.com/press-releases/detail/776/new-preclinical-data-show-can-fites-namodenoson-cf102-inhibits-liver-fibrosis—-supports-potential-efficacy-in-treatment-of-nash
Europe approves focused ultrasound treatment for prostate cancer. (TY Atid-EDI) I reported previously (several times) on the focused ultrasound treatment from Israel’s Insightec to cure shaking and remove uterine fibroids. Now Insightec has been given the CE mark to use focused ultrasound to treat prostate cancer.
http://www.insightec.com/news-events/press-releases/2016/insightec-receives-ce-mark-for-the-exablate-prostate-for-treating-locally-confined-prostate-cancer
Patching up the brain after surgery. Israeli biotech Nurami Medical is developing the ArtiFascia, a biodegradable nanofiber patch that protects brain tissue and spinal cord damaged during neurosurgery. Nurami, founded by Jewish and Arab graduates, has just secured NIS 2.5 million ($650,000) of funds.
http://www.timesofisrael.com/israeli-biotechnology-startup-nurami-medical-raises-nis-2-5m/
Diagnosing sleep apnea by smartphone. Ben-Gurion University researchers have developed a system to assess obstructive sleep apnea (OSA) severity by analyzing the patient’s speech using his or her smartphone. It also records and evaluates overnight breathing sounds and has been tested successfully on 350 subjects.
https://aabgu.org/smartphone-diagnoses-sleep-apnea/
A shining example. Former Lieutenant Colonel Yossie Cohen made many life and death decisions in the IDF. But he never thought that filling in a form at the Ezer Mizion Bone Marrow Registration Station was one of them. Ten years later he received a phone call. He donated some cells and gave another man the gift of life.
http://www.ezermizion.org/blog/a-shining-example/
Universal flu vaccine – latest news. Knowing many sufferers of the current flu bout, it is timely to report positive preliminary results in the Phase 2b trials of the Universal Flu vaccine from Israel’s BiondVax. And thanks to a $2.8 million investment (see Jan 15), BiondVax is to “proceed confidently into Phase 3 as planned.”
http://www.biondvax.com/2016/11/biondvax-phase-2b-trial-preliminary-safety-results-the-universal-flu-vaccine-candidate-is-safe-and-well-tolerated/